CLIA Waived 14 Drug Test Dip Card FEN, EDDP

CLIA Waived 14 Drug Test Dip Card

Your complete solution for professional drug testing. Whether you’re testing in a clinic, lab, workplace, or at home, this CLIA Waived 14 Drug Test Dip Card is trusted by healthcare professionals and employers across the U.S. to deliver accurate and instant results. Detect 14 of the most commonly abused substances with confidence.

✅ Key Features

• Comprehensive 14 Drug Panel Coverage – Detects fentanyl (FEN), nor-methadone metabolite (EDDP), tricyclic antidepressants (TCA), marijuana (THC), amphetamines (AMP), cocaine (COC), barbiturates (BAR), buprenorphine (BUP), benzodiazepines (BZO), ecstasy (MDMA), methamphetamine (MET), morphine (MOR), methadone (MTD), and oxycodone (OXY).
• CLIA Waived & FDA 510(k) Cleared – Certified for medical and clinical use; safe for point-of-care testing.
• Rapid Results in Under 5 Minutes – Easy-to-read results with clearly visible test lines for each drug class.
• Individually Sealed & Sterile – Each dip card is hygienically sealed for single use and long shelf life (up to 24 months).
• No Lab Required – Just dip, wait, and read—no special training or lab equipment needed.

What does a 14 panel drug screen test for:

🩺 What is a 14 panel drug test?

A CLIA waived 14 panel drug test is a diagnostic urine test card certified for use in point-of-care settings under the Clinical Laboratory Improvement Amendments (CLIA). Being CLIA waived means it meets strict regulatory standards for reliability and can be used by healthcare professionals, employers, and even individuals for on-site drug screening.

💡 Why Choose 14 panel urine test?

🔹 Detection of Dangerous Drugs

Includes Fentanyl, a highly potent opioid responsible for a growing number of overdose deaths. Also includes EDDP, a primary metabolite of Methadone, making this test ideal for addiction treatment programs and pain management compliance.

🔹 Superior Accuracy

Uses high-sensitivity immunoassay technology to deliver precise and reliable results. Built-in control lines indicate whether the test is valid.

🔹 Fast, Hassle-Free Use

Just remove from foil pouch, dip into the urine sample for 10–15 seconds, and lay flat. Results are visible within 5 minutes, with two lines indicating negative and one line (control only) indicating positive.

🔹 Zero Guesswork

Unlike traditional test kits, these dip cards are clearly labeled and formatted for easy interpretation, minimizing user error.

🏥 Who Is This 14 panel drug screen for?

• Clinics & Doctors’ Offices – Ideal for patient screenings, pain management evaluations, and pre-surgical assessments.
• Rehab & Treatment Centers – Quickly monitor recovery progress and detect potential relapses with specific metabolites like EDDP and BUP.
• Employers & HR Departments – Conduct workplace testing and pre-employment screening with confidence and ease.
• Parole, Probation & Law Enforcement – On-the-spot drug testing for probationers and parolees.
• Schools, Sports & Youth Programs – Ensure substance-free participation in extracurricular activities.
• Parents & Guardians – Test privately at home for peace of mind.

🔐 Safety & Storage

• Store at room temperature (36–78°F)
• Keep sealed until ready to use
• Do not freeze
• Use immediately after opening

📊 Test Accuracy & Quality Assurance

• Accuracy: >99% at designated cutoff levels
• Sensitivity/Specificity: Comparable to lab-based immunoassay screens
• Certifications: CLIA Waived, FDA 510(k) Cleared
• Manufacturing: Made in FDA registered facilities under strict quality standards

📈 Compare to Other Drug Tests

This 14 panel drug test gives you the best value per panel compared to other drug testing kits while expanding the scope of detection.

🔬 Why EDDP and Fentanyl Matter

• EDDP is a primary metabolite of Methadone, which is used in pain management and addiction therapy. A test that detects EDDP ensures active Methadone use, even if Methadone itself has cleared from the system.
• Fentanyl is a synthetic opioid 50 to 100 times more potent than morphine. Its misuse has contributed to a sharp rise in overdose deaths. Many drug tests fail to detect Fentanyl unless specifically formulated to do so. This 14 drug test includes a sensitive FEN panel to detect exposure at levels as low as 1 ng/mL.

✅ CLIA Waived & FDA 510(k) Cleared – Trusted Accuracy

This 14 panel drug test is CLIA waived, making it suitable for use in clinical environments without the need for complex lab equipment. It also carries FDA 510(k) clearance, certifying it for sale and use under federal safety and efficacy guidelines.

Each card undergoes rigorous quality control to ensure test line accuracy, clarity, and sensitivity. Whether you’re conducting workplace screenings, checking patient compliance, or using it at home, you’ll have professional-grade reliability at your fingertips.